Next 10 |
As part the transition strategy to developing gene therapy solutions for orphan inherited retinal diseases, Ophthotech (NASDAQ: OPHT ) is changing its name to IVERIC bio. More news on: Ophthotech Corporation, Healthcare stocks news, Read more ...
- Company’s Shares Will Trade Under New Ticker Symbol: ISEE – Ophthotech Corporation (Nasdaq:OPHT) today announced that as part of its transition strategy to focus on discovering and developing novel gene therapy solutions to treat orphan inherited retinal diseases (IR...
Anadarko Petroleum (NYSE: APC ) +32% on being acquired by Chevron. More news on: Anadarko Petroleum Corporation, Kitov Pharma Ltd, Qudian Inc., Stocks on the move, Read more ...
Ophthotech Corporation (NASDAQ: OPHT) announced today that the Company has converted its option and entered into an exclusive global license agreement with the University of Pennsylvania (Penn), including the Perelman School of Medicine at the University of Pennsylvania and the University ...
Thinking about pipelines One of the ongoing lessons I take from observing the business world is the importance of a company taking prudent risks. Another observation as an investor is the value of companies that under-promise and over-deliver. The Biogen ( BIIB ) stock crash Thursday on t...
Noteworthy events during the week of March 17 - 23 for healthcare investors. More news on: SCYNEXIS, Inc., Sage Therapeutics, Inc., Intrexon Corporation, Healthcare stocks news, , Read more ...
Ophthotech Corporation (Nasdaq: OPHT) announced today that Kourous A. Rezaei, M.D., Chief Medical Officer, will present an overview of the Company at the Alliance for Regenerative Medicine’s (ARM) 7 th Annual Cell and Gene Therapy Investor Day in New York, NY, on Thursday, March 21...
Ophthotech Corporation (Nasdaq: OPHT) announced today that Kourous A. Rezaei, M.D., Chief Medical Officer of Ophthotech, will present an overview of the Company at the Cowen and Company 39 th Annual Health Care Conference in Boston, MA, on Wednesday, March 13, 2019 at 9:20 a.m. Eastern Ti...
Ophthotech Corporation (OPHT) Q4 2018 Results Earnings Conference Call February 26, 2019 08:00 AM ET Company Participants Kathy Galante - IR Glenn Sblendorio - CEO and President David Guyer - Executive Chairman Kourous Rezaei - CMO Dave Carroll - CFO Keith Westby - COO Vi...
- Conference Call and Webcast Today, February 26, 2019, at 8:00 a.m. ET - Ophthotech Corporation (Nasdaq: OPHT) today announced financial and operating results for the fourth quarter and full year ended December 31, 2018 and provided a business update. “2018 was a signifi...
News, Short Squeeze, Breakout and More Instantly...
Ophthotech Corporation Company Name:
OPHT Stock Symbol:
NASDAQ Market:
Ophthotech Corporation Website:
- Company’s Shares Will Trade Under New Ticker Symbol: ISEE – Ophthotech Corporation (Nasdaq:OPHT) today announced that as part of its transition strategy to focus on discovering and developing novel gene therapy solutions to treat orphan inherited retinal diseases (IR...
Ophthotech Corporation (NASDAQ: OPHT) announced today that the Company has converted its option and entered into an exclusive global license agreement with the University of Pennsylvania (Penn), including the Perelman School of Medicine at the University of Pennsylvania and the University ...
Ophthotech Corporation (Nasdaq: OPHT) announced today that Kourous A. Rezaei, M.D., Chief Medical Officer, will present an overview of the Company at the Alliance for Regenerative Medicine’s (ARM) 7 th Annual Cell and Gene Therapy Investor Day in New York, NY, on Thursday, March 21...